Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study | Zendy

Andrea CasadeiGardini | Zendy; Emanuela Scarpi | Zendy; Paola Ulivi | Zendy; Maria Angela Palladino | Zendy; Caterina Accettura | Zendy; Ilaria Bernardini | Zendy; Andrea Spallanzani | Zendy; Fabio Gelsomino | Zendy; Jody Corbelli | Zendy; Giorgia Marisi | Zendy; Silvia Ruscelli | Zendy; Martina Valgiusti | Zendy; Giovanni Luca Frassineti | Zendy; Alessandro Passardi | Zendy

Open Access

<p>Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study</p>

Author(s) -

Andrea CasadeiGardini,

Emanuela Scarpi,

Paola Ulivi,

Maria Angela Palladino,

Caterina Accettura,

Ilaria Bernardini,

Andrea Spallanzani,

Fabio Gelsomino,

Jody Corbelli,

Giorgia Marisi,

Silvia Ruscelli,

Martina Valgiusti,

Giovanni Luca Frassineti,

Alessandro Passardi

Publication year - 2019

Publication title -

cancer management and research

Language(s) - English

Resource type - Journals

ISSN - 1179-1322

DOI - 10.2147/cmar.s198651

Subject(s) - bevacizumab , medicine , colorectal cancer , gastroenterology , lactate dehydrogenase , neutrophil to lymphocyte ratio , oncology , chemotherapy , regimen , cancer , lymphocyte , biochemistry , chemistry , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research